The ongoing indirect effect of the COVID-19 pandemic on a pediatric emergency department

Matti Erlichman1, Todd Zalut2, Shepard Schwartz1

  • 1Shaare Zedek Medical Center and the Faculty of Medicine at the Hebrew University in Jerusalem, Pediatric Emergency Department, Jerusalem, Israel.

Plos One
|May 6, 2021
PubMed

Insights

The COVID-19 pandemic significantly reduced pediatric emergency department visits, yet hospitalization rates increased during lockdowns. This trend persisted post-lockdown, emphasizing the need for public awareness regarding children's emergency care.

Area of Science:

  • Public Health
  • Pediatrics
  • Epidemiology

Background:

  • The COVID-19 pandemic has impacted healthcare delivery, particularly pediatric emergency departments (PEDs).
  • Understanding the pandemic's effect on children's healthcare access is crucial.

Purpose of the Study:

  • To assess the impact of the COVID-19 pandemic and associated social restrictions on PED visits and hospitalizations.
  • To compare trends with adult emergency departments (EDs) and analyze changes over time relative to pandemic severity.

Main Methods:

  • Retrospective analysis of daily PED and adult ED visits and hospitalizations at Shaare Zedek Medical Center from January to July 2018-2020.
  • Comparison of hospitalization risk ratios and incidence rate ratios between 2019 and 2020.

Main Results:

  • During March-April 2020, PED visits decreased by 45% compared to 2019, with a 31% increase in hospitalization risk ratio.
  • Adult EDs showed similar, though less pronounced, trends.
  • From May-July 2020, PED visits remained 30% below pre-pandemic levels, while hospitalization rates normalized.

Conclusions:

  • A significant decline in pediatric emergency visits extended beyond the initial lockdown period.
  • This highlights a potential risk of delayed medical attention for critically ill children.
  • Public awareness campaigns are essential to ensure children receive timely care during health crises.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
84
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
62
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
71
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
53
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
53
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
211